Cite
Lee HJ, Jo DS, Kim YK, et al. One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea. Clin Exp Vaccine Res. 2019;8(2):94-102doi: 10.7774/cevr.2019.8.2.94.
Lee, H. J., Jo, D. S., Kim, Y. K., Lee, H., Kim, K. H., Lee, D., Curina, C., Costantini, M., Barbi, S., Miao, Y., & Pellegrini, M. (2019). One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea. Clinical and experimental vaccine research, 8(2), 94-102. https://doi.org/10.7774/cevr.2019.8.2.94
Lee, Hoan-Jong, et al. "One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea." Clinical and experimental vaccine research vol. 8,2 (2019): 94-102. doi: https://doi.org/10.7774/cevr.2019.8.2.94
Lee HJ, Jo DS, Kim YK, Lee H, Kim KH, Lee D, Curina C, Costantini M, Barbi S, Miao Y, Pellegrini M. One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea. Clin Exp Vaccine Res. 2019 Jul;8(2):94-102. doi: 10.7774/cevr.2019.8.2.94. Epub 2019 Jul 31. PMID: 31406690; PMCID: PMC6689500.
Copy
Download .nbib